114 related articles for article (PubMed ID: 34987126)
1. 5-aminosalicylic acid inhibits the expression of oncomiRs and pro-inflammatory microRNAs: an in vitro study.
Adamowicz M; Milkiewicz P; Kempinska-Podhorodecka A
J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987126
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a.
Min M; Peng L; Yang Y; Guo M; Wang W; Sun G
Inflamm Bowel Dis; 2014 Apr; 20(4):652-9. PubMed ID: 24583476
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
4. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.
Pathak S; Grillo AR; Scarpa M; Brun P; D'Incà R; Nai L; Banerjee A; Cavallo D; Barzon L; Palù G; Sturniolo GC; Buda A; Castagliuolo I
Exp Mol Med; 2015 May; 47(5):e164. PubMed ID: 25998827
[TBL] [Abstract][Full Text] [Related]
5. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
6. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
[TBL] [Abstract][Full Text] [Related]
7. miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.
Minacapelli CD; Bajpai M; Geng X; Van Gurp J; Poplin E; Amenta PS; Brant SR; Das KM
Inflamm Bowel Dis; 2019 Jan; 25(1):78-84. PubMed ID: 30204869
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
[TBL] [Abstract][Full Text] [Related]
9. Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3.
Qin Z; Wan JJ; Sun Y; Wu T; Wang PY; Du P; Su DF; Yang Y; Liu X
J Mol Med (Berl); 2017 Feb; 95(2):221-233. PubMed ID: 27709266
[TBL] [Abstract][Full Text] [Related]
10. miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7.
Chen G; Cao S; Liu F; Liu Y
Biochem J; 2015 Nov; 471(3):357-67. PubMed ID: 26303523
[TBL] [Abstract][Full Text] [Related]
11. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease.
Kim HY; Kwon HY; Ha Thi HT; Lee HJ; Kim GI; Hahm KB; Hong S
J Gastroenterol Hepatol; 2016 Oct; 31(10):1727-1735. PubMed ID: 26878986
[TBL] [Abstract][Full Text] [Related]
13. Elevated miRNA Inversely Correlates with
Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
[TBL] [Abstract][Full Text] [Related]
14. microRNA-15 Activates NF-κB Pathway via Down Regulating Expression of Adenosine A2 Receptor in Ulcerative Colitis.
Zhang H; Li W
Cell Physiol Biochem; 2018; 51(4):1932-1944. PubMed ID: 30513523
[TBL] [Abstract][Full Text] [Related]
15. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα.
Feng X; Wang H; Ye S; Guan J; Tan W; Cheng S; Wei G; Wu W; Wu F; Zhou Y
PLoS One; 2012; 7(12):e52782. PubMed ID: 23285182
[TBL] [Abstract][Full Text] [Related]
18. microRNA-650 promotes inflammation induced apoptosis of intestinal epithelioid cells by targeting NLRP6.
Xu X; Zhu X; Wang C; Li Y; Fan C; Kao X
Biochem Biophys Res Commun; 2019 Oct; 517(4):551-556. PubMed ID: 31399193
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
Valmiki S; Ahuja V; Paul J
World J Gastroenterol; 2017 Aug; 23(29):5324-5332. PubMed ID: 28839432
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
Cevallos SA; Lee JY; Velazquez EM; Foegeding NJ; Shelton CD; Tiffany CR; Parry BH; Stull-Lane AR; Olsan EE; Savage HP; Nguyen H; Ghanaat SS; Byndloss AJ; Agu IO; Tsolis RM; Byndloss MX; Bäumler AJ
mBio; 2021 Jan; 12(1):. PubMed ID: 33468700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
